Moderna, Inc.
27.12.2021 15:54:21 CET | ACCESS Newswire | Press release
Total of 27.5 million doses ordered by the Swiss Federal Government to date
CAMBRIDGE, MA / ACCESSWIRE / December 27, 2021 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Swiss Federal Government has exercised its option to purchase an additional seven million doses of Moderna's booster vaccine for delivery in the second half of 2022. These doses are in addition to the initial seven million doses of booster vaccine the Swiss Federal Government agreed to purchase for delivery in 2022 and brings Switzerland's order commitment to a total of 27.5 million doses.
"We appreciate the collaboration with the Swiss Federal Government, and their continued support demonstrated by their increased supply agreement," said Stéphane Bancel, Chief Executive Officer of Moderna. "We are encouraged by the initial data showing that the currently authorized Moderna COVID-19 booster can boost neutralizing antibody levels against the Omicron variant 37-fold higher than pre-boost levels. We will continue to make as many updates to our COVID-19 vaccine as necessary to control the pandemic."
Authorized Use
SPIKEVAX (elasomeran mRNA vaccine) has been granted approval by Swissmedic and is indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 12 years of age and older.
About Moderna
In 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna's capabilities have come together to allow the authorized use of one of the earliest and most-effective vaccines against the COVID-19 pandemic.
Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past seven years. To learn more, visit www.modernatx.com.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including regarding: the Company's contract to sell its COVID-19 vaccine to the Swiss Federal Government; the timing for delivery of those sales; the effectiveness of the Company's COVID-19 booster; and the Company's plans to update its COVID-19 vaccine. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna's control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include those risks and uncertainties described under the heading "Risk Factors" in Moderna's most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) and in subsequent lings made by Moderna with the SEC, which are available on the SEC's website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna's current expectations and speak only as of the date hereof.
Moderna Contacts
Media:
Colleen Hussey
Director, Corporate Communications
617-335-1374
Colleen.Hussey@modernatx.com
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View source version on accesswire.com:
https://www.accesswire.com/679648/Moderna-Announces-Switzerland-Exercises-its-Option-to-Purchase-Seven-Million-Additional-Doses-of-Modernas-COVID-19-Booster-Vaccine-in-2022
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Chervon Names Charlie Harte Director of Field Sales & Recruiting - Canada12.10.2026 16:00:00 CEST | Press release
NAPERVILLE, IL / ACCESS Newswire / October 12, 2026 / Charlie Harte joins Chervon as Director of Field Sales and Recruiting - Canada, effective Monday, October 12, 2026, reporting to Neil Harrison, VP/MD Sales and Marketing - Canada. Harte brings 15+ years of experience in the Canadian power tools, outdoor power equipment, and hand tool market. Additionally, he has 6+ years of experience selling into the commercial plumbing arena. Early in his career, Harte spent six years at Black and Decker growing into the National Sales and Marketing Manager position for B&D Canada. He subsequently became Director of Sales for Irwin Industrial Tools and then became a Director of Sales for Milwaukee Canada. Harte moved into the VP Sales position for Uponor Advanced Plumbing Solutions. Harte has an impressive track record in field sales leadership and strategic account development. He is known for his ability to build and manage high-performance sales teams throughout Canada. "Charlie brings an outst
Chervon Names Thomas G. Kentouris Vice President of Field Sales12.10.2026 15:00:00 CEST | Press release
NAPERVILLE, IL / ACCESS Newswire / October 12, 2026 / Thomas G. Kentouris joins Chervon as Vice President of Field Sales, effective Monday, October 12, 2026, reporting to Matt DeFeo, SVP of Sales Training and Recruiting. Kentouris brings 14+ years of Power Tool and Outdoor Power Equipment experience at TTI. His career began as a sales rep and advanced through a series of increasingly responsible positions, culminating in SVP of Field Sales for Eastern U.S.A. Kentouris delivered exceptional sales growth results year after year in his areas of responsibility. His ability to develop store-level partnerships and store-level sell-through programs all resulted in exceptional levels of success. Kentouris distinguished himself as an outstanding recruiting talent as he and his teams were responsible for recruiting over 2,000 high potential recent college graduates into the TTI system. Kentouris did an amazing job mentoring, developing, and promoting hundreds of his people into higher level posi
Chervon Names Randall Durkan Vice President of Supply Chain - North America12.10.2026 15:00:00 CEST | Press release
NAPERVILLE, IL / ACCESS Newswire / October 12, 2026 / Randy Durkan joins Chervon as Vice President of Supply Chain - North America, effective Monday, October 12, 2026, reporting to CEO Joe Galli. Randy Durkan brings over 25 years of supply chain management experience, including extensive leadership in power tools, hand tools, and outdoor power equipment. He has proven experience building high-performance supply chain teams and has consistently delivered outstanding service levels, inventory optimization, and cost-reduction results. Durkan is known for developing strong supply chain partnerships with key customers, driving cross-functional collaboration, and deploying technology to achieve world-class supply chain performance. He began his early supply chain career in Bentonville, Arkansas, supporting Walmart-focused collaboration across several consumer goods companies. His work at Vi-Jon contributed to Walmart's 2008 Supplier of the Year Award. Durkan then spent six years in supply ch
Miami Fashion Week(R) Celebrates 10 Years With a Landmark Anniversary Edition, October 13-18, 20269.10.2026 17:00:00 CEST | Press release
MIAMI, FL / ACCESS Newswire / October 9, 2026 / Miami Fashion Week® (MIAFW) celebrates its 10th anniversary this year, returning October 13-18, 2026 featuring industry programming, runway shows, and special events bringing together international designers, Latin American talent and Miami's creative community. For a decade, MIAFW has served as a bridge between Miami and the international fashion industry, creating a platform for designers while expanding beyond the runway through sustainability, technology, education and cultural exchange. The milestone edition brings together international designers, Latin American talent, fashion innovation and a new Stitch Lab retail experience Throughout these ten years, MIAFW has pioneered initiatives at the intersection of fashion, sustainability and technology. Founded in 2017, the MIAFW Summit created a space for dialogue and education around the industry's evolving challenges and opportunities. Building on that vision, the Virtual Fashion Award
IROS 2026|PaXini Showcases Full-Stack Tactile Strategy for Physical AI8.10.2026 18:15:00 CEST | Press release
PITTSBURGH, PA / ACCESS Newswire / October 8, 2026 / As global researchers and industry leaders gathered in Pittsburgh for IROS 2026 (Sep. 27-Oct. 1) to tackle the scaling of Physical AI, PaXini AI took center stage, showcasing its full-stack products from chips to humanoid robots and hosting GEEN 2026 · IROS, the Global Embodied Ecosystem Night. The event was not merely an exchange, but an industry gathering focused on the deployment of embodied intelligence. As a leader in tactile sensing, PaXini has built a full-stack closed loop centered on touch: PIE - Perception, Intelligence, Execution. Perception enables robots to understand the real environment more comprehensively and accurately. Intelligence uses data and experience to move robots from being programmed to adapting and generalizing. Execution, through powerful actuators and dexterous end-effectors, allows robots to complete complex tasks. These three layers drive one another and form PaXini's infrastructure capability for the
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom